EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Neoadjuvant therapy with anlotinib in a locally advanced and pulmonary metastasis PTC patient harboring TERT promoter and BRAFV600E mutations: a case report

Yan-Jun Su, Shao-Hao Cheng, Jun Qian, Ming Zhang, Wen Liu, Xiang-Xiang Zhan, Zhu-Quan Wang, Hai-Dan Liu, Xing-Wei Zhong, Ruo-Chuan Cheng

Archives of Endocrinology and Metabolism · 2023

DOI: 10.20945/2359-3997000000659 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Archives of Endocrinology and Metabolism, 2023. Verfasst von Yan-Jun Su und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary, Telomerase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, PapillaryTelomeraseFemaleHumansAgedThyroid Cancer, PapillaryProto-Oncogene Proteins B-rafNeoadjuvant TherapyIodine RadioisotopesNeoplasm Recurrence, LocalMutationIndolesQuinolines

Substanzen

Proto-Oncogene Proteins B-rafIodine RadioisotopesTelomeraseanlotinibIndolesQuinolinesTERT protein, humanBRAF protein, human

Autor:innen und Institutionen

  • Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China.
  • Department of General Surgery, The First People's Hospital of Honghe State, Mengzi, PR. China.
  • Department of General Surgery, The First People's Hospital of Honghe State, Mengzi, PR. China, 13988002917@163.com.
  • Department of Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China, ruochuan@foxmail.com.

Zitieren

APA

Su, Y. J., Cheng, S. H., Qian, J., Zhang, M., Liu, W., Zhan, X. X., Wang, Z. Q., Liu, H. D., Zhong, X. W., & Cheng, R. C. (2023). Neoadjuvant therapy with anlotinib in a locally advanced and pulmonary metastasis PTC patient harboring TERT promoter and BRAFV600E mutations: a case report. Archives of Endocrinology and Metabolism. https://doi.org/10.20945/2359-3997000000659

Vancouver

Su YJ, Cheng SH, Qian J, Zhang M, Liu W, Zhan XX, et al. Neoadjuvant therapy with anlotinib in a locally advanced and pulmonary metastasis PTC patient harboring TERT promoter and BRAFV600E mutations: a case report. Archives of Endocrinology and Metabolism. 2023. doi:10.20945/2359-3997000000659

BibTeX
@article{Su2023,
  author = {Su, Yan-Jun and Cheng, Shao-Hao and Qian, Jun and Zhang, Ming and Liu, Wen and Zhan, Xiang-Xiang and Wang, Zhu-Quan and Liu, Hai-Dan and Zhong, Xing-Wei and Cheng, Ruo-Chuan},
  title = {Neoadjuvant therapy with anlotinib in a locally advanced and pulmonary metastasis PTC patient harboring TERT promoter and BRAFV600E mutations: a case report},
  journal = {Archives of Endocrinology and Metabolism},
  year = {2023},
  doi = {10.20945/2359-3997000000659}
}
Kostenlos starten →